CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2016	Dec. 31, 2015
Current assets
Cash	$ 54,706	$ 15,655
Other current assets	2,151	498
Total current assets	56,857	16,153
Land held for development (Note 3)	5,476,097	5,476,097
Deferred financing costs (net of amortization of $74,913 at June 30, 2016 and $56,218 at December 31, 2015)	126,187	144,882
Other assets	80	80
Total assets	5,659,221	5,637,212
Current liabilities
Notes, line of credit and advances payable (Note 5) due to related parties	100,000	75,000
Notes, line of credit and advances payable (Note 5) other	1,910,000	1,887,500
Short term financing agreement	1,501
Accounts payable and accrued expenses due related parties (Note 4)	2,469,287	2,204,545
Accounts payable and accrued expenses - other (Note 4)	1,829,449	1,867,867
Total current liabilities	6,310,237	6,034,912
Debenture payable (net of unamortized discount of $46,704 at June 30, 2016 and $47,703 at December 31, 2015) (Note 6)	3,296	2,297
Convertible debentures payable (net of unamortized discount of $1,704,156 at June 30, 2016 and $1,733,157 at December 31, 2015) (Note 6)	95,844	66,843
Derivative liability (Note 6)	1,894,670	1,704,570
Total liabilities	8,304,047	7,808,622
Commitments and contingencies (Notes 2, 3,5,6 and 8)
Stockholders' deficiency (Note 8)
Preferred stock, $.01 par value; shares authorized 5,000,000, outstanding 2,086,000 at June 30, 2016 and December 31, 2015 (aggregate liquidation preference of $2,519,080 at June 30, 2016 and December 31,2015).	20,860	20,860
Common stock, $.001 par value; shares authorized 50,000,000, issued: 39,052,472 at June 30, 2016 and December 31, 2015, outstanding: 36,297,576 at June 30, 2016 and December 31, 2015.	39,052	39,052
Additional paid-in capital	35,757,201	35,757,201
Unearned ESOP shares	(3,439,476)	(3,439,476)
Accumulated deficit	(34,881,725)	(34,408,309)
Treasury stock, at cost, 448,071 shares at June 30, 2016 and December 31, 2015	(140,738)	(140,738)
Total stockholders' deficiency	(2,644,826)	(2,171,410)
Total liabilities and stockholders deficiency	$ 5,659,221	$ 5,637,212